Mettler-Toledo International (MTD)
Market Price (12/18/2025): $1384.9301 | Market Cap: $28.4 BilSector: Health Care | Industry: Life Sciences Tools & Services
Mettler-Toledo International (MTD)
Market Price (12/18/2025): $1384.9301Market Cap: $28.4 BilSector: Health CareIndustry: Life Sciences Tools & Services
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 28% | Weak multi-year price returns2Y Excs Rtn is -25%, 3Y Excs Rtn is -75% | Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 25x, P/EPrice/Earnings or Price/(Net Income) is 30x |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 25%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 23% | Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.4% | |
| Low stock price volatilityVol 12M is 34% | Key risksMTD key risks include [1] prolonged economic weakness in key Chinese and European markets hindering margin recovery and [2] sales-damaging shipping delays caused by a new European logistics provider. | |
| Megatrend and thematic driversMegatrends include Automation & Robotics, and Precision Medicine. Themes include Factory Automation, Process / Warehouse Automation, Show more. |
| Attractive operating marginsOp Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is 28% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 25%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 23% |
| Low stock price volatilityVol 12M is 34% |
| Megatrend and thematic driversMegatrends include Automation & Robotics, and Precision Medicine. Themes include Factory Automation, Process / Warehouse Automation, Show more. |
| Weak multi-year price returns2Y Excs Rtn is -25%, 3Y Excs Rtn is -75% |
| Expensive valuation multiplesP/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 25x, P/EPrice/Earnings or Price/(Net Income) is 30x |
| Weak revenue growthRev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is 0.4% |
| Key risksMTD key risks include [1] prolonged economic weakness in key Chinese and European markets hindering margin recovery and [2] sales-damaging shipping delays caused by a new European logistics provider. |
Valuation, Metrics & Events
MTD Stock
Why The Stock Moved
Qualitative Assessment
AI Generated Analysis | Feedback
**1. Strong Third Quarter 2025 Financial Results**
Mettler-Toledo International (MTD) reported robust third-quarter 2025 results, with reported sales increasing by 8% and local currency sales growing by 6% compared to the prior year. Adjusted Earnings Per Share (EPS) for the quarter rose to $11.15, marking a 9% increase over the previous year. These strong financial performances likely fueled positive investor sentiment during the period.
**2. Share Repurchase Program Authorization**
The company's Board of Directors authorized an additional $2.75 billion for its share repurchase program in the third quarter of 2025, with $1.1 billion remaining as of September 30, 2025. This significant authorization indicates management's confidence in the company's financial health and its commitment to returning value to shareholders, which can positively impact stock price.
**3. Positive Analyst Rating Upgrades**
Several analysts upgraded MTD's stock rating within the timeframe. Bank of America, for instance, upgraded Mettler-Toledo from "neutral" to "buy" around December 15, 2025, setting a $1,600 price target that implied a roughly 13.24% upside from its prior close. This upgrade reflects increased analyst confidence in the company's future performance.
**4. Increased Analyst Price Targets**
Multiple financial analysts revised their price targets for MTD upwards. Stifel, on November 10, 2025, maintained a 'Buy' rating and raised its price target from $1,450 to $1,600, a 10.34% increase. Wells Fargo also maintained an 'Equal-Weight' rating, increasing its price target from $1,200 to $1,400 on the same date. These upward revisions signal a more optimistic outlook for the stock's future value.
**5. Favorable Market Outlook and Forecasted Upside**
Analyst consensus maintained a "Buy" or "Hold" rating for MTD, with an average price target that suggested a notable upside. Specifically, Wall Street analysts predicted Mettler-Toledo International's share price could reach $1,463.00 by December 9, 2026, representing a potential upside of 6.68% from the current MTD share price of $1,371.42. This projected growth aligns closely with the observed 6.4% stock movement, driven by anticipated strong earnings and revenue in 2025 and beyond.
Stock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| MTD Return | 44% | 49% | -15% | -16% | 1% | 13% | 75% |
| Peers Return | 37% | 44% | -16% | -7% | 2% | 0% | 56% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 14% | 108% |
Monthly Win Rates [3] | |||||||
| MTD Win Rate | 58% | 75% | 33% | 33% | 42% | 58% | |
| Peers Win Rate | 65% | 82% | 42% | 47% | 45% | 45% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| MTD Max Drawdown | -26% | -9% | -36% | -33% | -7% | -21% | |
| Peers Max Drawdown | -26% | -6% | -31% | -29% | -8% | -25% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: TMO, DHR, A, WAT, RVTY. See MTD Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/17/2025 (YTD)
How Low Can It Go
| Event | MTD | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -43.5% | -25.4% |
| % Gain to Breakeven | 76.9% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -29.4% | -33.9% |
| % Gain to Breakeven | 41.7% | 51.3% |
| Time to Breakeven | 72 days | 148 days |
| 2018 Correction | ||
| % Loss | -26.3% | -19.8% |
| % Gain to Breakeven | 35.7% | 24.7% |
| Time to Breakeven | 334 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -61.4% | -56.8% |
| % Gain to Breakeven | 159.3% | 131.3% |
| Time to Breakeven | 413 days | 1,480 days |
Compare to TMO, DHR, ITW, A, AVRT
In The Past
Mettler-Toledo International's stock fell -43.5% during the 2022 Inflation Shock from a high on 12/30/2021. A -43.5% loss requires a 76.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
Trade Ideas
Select past ideas related to MTD. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 16.3% | 16.3% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -7.1% | -7.1% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 3.6% | 3.6% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 1.6% | 1.6% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 14.1% | 14.1% | -5.1% |
| 05312025 | MTD | Mettler-Toledo International | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 27.8% | 20.0% | -1.2% |
| 10312023 | MTD | Mettler-Toledo International | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 24.8% | 32.2% | -1.6% |
| 10312022 | MTD | Mettler-Toledo International | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 20.1% | -22.1% | -23.9% |
| 04302022 | MTD | Mettler-Toledo International | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | -1.0% | 16.7% | -15.1% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11142025 | CRL | Charles River Laboratories International | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 16.3% | 16.3% | -3.7% |
| 11142025 | GDRX | GoodRx | Dip Buy | DB | CFO/Rev | Low D/EDip Buy with High Cash Flow MarginsBuying dips for companies with significant cash flows from operations and reasonable debt / market cap | -7.1% | -7.1% | -11.8% |
| 11142025 | ASTH | Astrana Health | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 3.6% | 3.6% | -5.5% |
| 11142025 | SGRY | Surgery Partners | Dip Buy | DB | FCF Yield | Low D/EDip Buy with High Free Cash Flow YieldBuying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap | 1.6% | 1.6% | -1.4% |
| 11072025 | TFX | Teleflex | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 14.1% | 14.1% | -5.1% |
| 05312025 | MTD | Mettler-Toledo International | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 27.8% | 20.0% | -1.2% |
| 10312023 | MTD | Mettler-Toledo International | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 24.8% | 32.2% | -1.6% |
| 10312022 | MTD | Mettler-Toledo International | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 20.1% | -22.1% | -23.9% |
| 04302022 | MTD | Mettler-Toledo International | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | -1.0% | 16.7% | -15.1% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Mettler-Toledo International
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 299.88 |
| Mkt Cap | 33.6 |
| Rev LTM | 5,365 |
| Op Inc LTM | 1,276 |
| FCF LTM | 989 |
| FCF 3Y Avg | 1,098 |
| CFO LTM | 1,246 |
| CFO 3Y Avg | 1,326 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 3.9% |
| Rev Chg 3Y Avg | 0.1% |
| Rev Chg Q | 6.4% |
| QoQ Delta Rev Chg LTM | 1.6% |
| Op Mgn LTM | 20.1% |
| Op Mgn 3Y Avg | 21.2% |
| QoQ Delta Op Mgn LTM | -0.2% |
| CFO/Rev LTM | 22.7% |
| CFO/Rev 3Y Avg | 23.7% |
| FCF/Rev LTM | 18.5% |
| FCF/Rev 3Y Avg | 18.7% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 33.6 |
| P/S | 5.3 |
| P/EBIT | 22.5 |
| P/E | 29.0 |
| P/CFO | 23.2 |
| Total Yield | 3.5% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | 3.3% |
| D/E | 0.1 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -0.3% |
| 3M Rtn | 14.5% |
| 6M Rtn | 16.8% |
| 12M Rtn | 0.9% |
| 3Y Rtn | -3.0% |
| 1M Excs Rtn | -1.0% |
| 3M Excs Rtn | 10.9% |
| 6M Excs Rtn | 4.5% |
| 12M Excs Rtn | -11.7% |
| 3Y Excs Rtn | -75.3% |
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/6/2025 | -0.0% | -1.9% | -4.7% |
| 8/1/2025 | 2.9% | 4.9% | 6.6% |
| 5/1/2025 | 4.1% | 4.3% | 8.0% |
| 11/7/2024 | -7.2% | -12.3% | -9.2% |
| 8/1/2024 | -4.9% | -7.9% | -5.0% |
| 5/9/2024 | 17.0% | 18.6% | 11.9% |
| 2/8/2024 | -4.1% | -2.6% | 6.0% |
| 11/9/2023 | 1.9% | 2.5% | 8.6% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 11 | 10 | 11 |
| # Negative | 12 | 13 | 12 |
| Median Positive | 3.9% | 4.5% | 8.0% |
| Median Negative | -2.2% | -4.2% | -7.7% |
| Max Positive | 17.0% | 18.6% | 18.6% |
| Max Negative | -7.2% | -12.3% | -15.3% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 11072025 | 10-Q 9/30/2025 |
| 6302025 | 8012025 | 10-Q 6/30/2025 |
| 3312025 | 5022025 | 10-Q 3/31/2025 |
| 12312024 | 2072025 | 10-K 12/31/2024 |
| 9302024 | 11082024 | 10-Q 9/30/2024 |
| 6302024 | 8022024 | 10-Q 6/30/2024 |
| 3312024 | 5102024 | 10-Q 3/31/2024 |
| 12312023 | 2092024 | 10-K 12/31/2023 |
| 9302023 | 11092023 | 10-Q 9/30/2023 |
| 6302023 | 7282023 | 10-Q 6/30/2023 |
| 3312023 | 5052023 | 10-Q 3/31/2023 |
| 12312022 | 2102023 | 10-K 12/31/2022 |
| 9302022 | 11042022 | 10-Q 9/30/2022 |
| 6302022 | 7292022 | 10-Q 6/30/2022 |
| 3312022 | 5062022 | 10-Q 3/31/2022 |
| 12312021 | 2112022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |